IgM is expressed on the surface of B lymphocytes but not on the surface of IgMsecreting plasma cells . This shift from the expression of surface IgM to that of the secreted form is partly achieved by control at the level of RNA processing . However, post-translational regulation also plays a critical role . Thus, even when the membrane form of IgM is synthesized in plasmacytoma cells, it fails to reach the cell surface ; rather, it is retained within the endoplasmic reticulum (1, 2) . The molecular basis of this differential handling of surface IgM in B cells and plasma cells is not understood, although a B cell-specific protein that associates with membrane IgM has been proposed to play a role (3) . Here, we present experiments that suggest that the proteins that potentiate the surface expression of membrane IgM in B cells recognize the COOH-terminal end of p.m chains and work through interaction with the transmembrane segment.
unit into the unique Eco RI site of the parental plasmid. An expression vector for human CD8 (plasmid No . 782) was constructed by linking a CD8 cDNA Eco RI fragment (6) to the HCMV promoter and cloning into pSV2neo with the vector providing the poly A site (Fig . 1) . The hybrid CD8/C/,4-C/,M gene (CD8/u4m ; plasmid No. 808) was constructed by cutting the CD8 cDNA fragment at the Eco RV site just preceding its transmembrane region (6) and fusing to the ApaLI-XhoI C,,4-CM fragment of plasmid No . 463, in which the Apa LI site had been blunted by use of T4 polymerase and dGTP + dTTP The reading frame across the fusion junction was verified by sequencing; the gene was linked to the HCMV promoter and cloned into pSV2gpt.
Plasmacytoma J558L secretes X1 L chains . An Ig -derivative of mouse B cell lymphoma M12 (7) was obtained from B. Chain (University College, London). Transfection of lymphoid cell lines and COS-7 cells was carried out as previously described (4, 8) . The M12 and COS-7 cells were transfected with plasmids that included both the 1A and X chain transcription units, whereas pSV2gpt derivatives containing only the u chain unit were used forJ558L. COS-7 cells were trypsinized 24 h after transfection and distributed onto microscope slides ; immunofluorescence was performed 24 h later using a confocal microscope (1) on surface-stained cells or after fixation for 10 min in 4% paraformaldehyde in PBS and permeabilization with NP-40. Analysis in the FAGS with FITC-conjugated anti-,u or anti-CD8 (OKT8; Ortho Diagnostic Systems Inc., Westwood, MA) reagents was performed on surface-labeled cells or on cells labeled after fixation for 5 min in 3.8% formaldehyde in PBS and permeabilization for 3 min in 0.05% NP-40 in PBS.
Results
We have previously shown that transfectants of theJ558L plasmacytoma that make ,um and X chains retain the membrane IgM in the endoplasmic reticulum (1). However, surface IgM expression is achieved in transfectants of the B cell lymphoma M12 harboring a plasmid directing the synthesis of membrane IgM (Figs. 1 and In contrast to the membrane form, the secretory form of IgM proceeds through the Golgi of plasmacytoma and out of the cell . We therefore suspected that the intracellular retention of membrane IgM might be mediated through the COOHterminal end of tc. chains, as this is where IA . and us differ. To test this, we constructed a hybrid gene between CA and the human cell surface antigen CD8 (which has a single extracellular domain and is a member of the Ig superfamily) . The CD8/A4m hybrid gene ( Fig. 1) has the single extracellular CD8 domain linked to the p C4, transmembrane, and cytoplasmic portions, and encodes a glycoprotein of the predicted molecular weight (not shown) . When the CD8/A4m chimeric protein is made in M12 cells, it is transported to the cell surface; in COS-7 cells, however, it is retained within the cell (Figs. 2 B and 3 B ). This contrasts with CD8 itself, which is transported to the surface in both cell types (Fig . 3 B, and data not shown) . Thus, provision of the j. C4, transmembrane, and cytoplasmic portions is sufficient to confer on CD8 the B cell-specific transport phenotype of membrane IgM. These results not only indicate that the sequence responsible for the intracellular retention of membrane IgM in non-13 cells is located at the COOH-terminal end of IA ., but also that this part of u. is sufficient for recognition by those factors that facilitate surface IgM expression in B cells.
A Surface
Permeabilised C Surface Surface Mutating the Transmembrane Segment Permits Surface IgM Expression in Non-B Cells. The results with the CD8/A4 m protein suggest that alteration ofthe COOH-terminal end of Am might overcome the retention of membrane IgM by non-B cells. We therefore constructed a plasmid that directs the synthesis of a hybrid H chain that is composed of V , Cw1, C#2, Cf ,3, and CI A domains linked to the transmembrane and cytoplasmic segments of the MHC class I molecule H-2K b (Fig. 1) ; MHC class I molecules are expressed on the surface of a wide variety of cells. The hybrid g/H2 molecules associated with X L chains and were efficiently transported to the surface ofJ558L and M12 cells ( Fig. 2 C) ; they were also transported to the surface ofCOS-7 cells (Fig . 3 A) .
The fact that the IgM comprising the p/H2 H chains reached the cell surface must be due to the change either in the transmembrane segment or in the cytoplasmic tail. We felt that, given the short length of the hm cytoplasmic tail, the alteration ofthe transmembrane segment was the more likely cause. Inspection of the sequence of the segment of hm chains that spans the membrane (Fig. 4) reveals that while it contains no charged residues, it comprises two regions (TTAST and YSTTVT) that include polar amino acids. We therefore tested whether the mutant H chain p.,n*1 (Fig . 4) , in which these two regions of the l~t ransmembrane segment have been mutated so as to increase its hydrophobicity, would be transported to the cell surface. This was indeed the case (Fig. 2 D) . In fact, mutation of just the NH2-terminal portion of the transmembrane segment (mutant /Am*2) was sufficient to allow surface IgM expression in plasmacytoma (Fig. 2 D) . 
Discussion
Membrane IgM is only able to proceed onto the cell surface in B lymphocytes. In contrast, it is retained within the endoplasmic reticulum in plasmacytoma and nonlymphoid cells. However, mutation of the transmembrane segment overcomes this retention. This raises several questions. What retains membrane IgM within the endoplasmic reticulum of non-B cells? How does mutating the transmembrane segment overcome the retention? How is the retention obviated in surface IgM-expressing B lymphocytes?
Our demonstration that specific amino acid substitutions in the transmembrane segment overcome the retention of membrane IgM in non-B cells means that this retention must be mediated by interactions involving the transmembrane segment. What proteins could mediate the retention? The H chain binding protein (BiP), which is implicated in the intracellular retention of secretory IgM by B cells, is unlikely to play a role, as no association between BiP and membrane IgM is found in / , tm transfectants of the J558L plasmacytoma (9) . Rather, if a protein of the endoplasmic reticulum is involved, it is likely to be a resident transmembrane protein. However, the most striking feature of the mutant IA . chains is that they are more hydrophobic than the wild type. Therefore, it may simply be that the transmembrane segment is too hydrophilic for stable incorporation into the lipid bilayer; membrane incorporation might require a protein sheath .
How then do B cells overcome the intracellular retention of membrane IgM? Hombach et al . (3) have described the isolation of a variant of the J558L plasmacytoma that transports IgM to the cell surface, and have shown that this variant now expresses an IgM-associated protein (B34) that is absent from the parental J558L. The authors suggest that B34 is the product of the mb-1 gene isolated by Sakaguchi et al . (10) , and propose that B34 mediates the transport of membrane IgM to the cell surface. From the data we present here, it is evident that the factor(s) that mediate the transport of membrane IgM to the B cell surface need no more than the h C4, transmembrane, and cytoplasmic portions for recognition. They must act by either forming a sheath that allows stable incorporation of the g transmembrane segment into the lipid bilayer, or they must displace an interaction that involves the transmembrane segment and that would otherwise cause retention. 
